Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Metabias: A Challenge for Comparative Effectiveness Research

(2013) Steven Goodman et al.   ANNALS OF INTERNAL MEDICINE

Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia

(2011) Phillip Scheinberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine

(2010) P. Scheinberg et al.   HAEMATOLOGICA

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia

(2009) David Gómez-Almaguer et al.   ANNALS OF HEMATOLOGY

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA

(2009) Antonio Maria Risitano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents

(2009) Carlo Piccinni et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study

(2009) P. Scheinberg et al.   HAEMATOLOGICA

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience

(2009) K. Quillen et al.   HAEMATOLOGICA

A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome

(2008) Hawk Kim et al.   LEUKEMIA RESEARCH

Monoclonal Antibodies for the Treatment of Hematologic Malignancies: Schedule and Maintenance Therapy

(2008) Alden Moccia et al.   SEMINARS IN HEMATOLOGY

Why Current Publication Practices May Distort Science

(2008) Neal S Young et al.   PLOS MEDICINE

Alemtuzumab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

(2007) David Gómez-Almaguer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION